Oxprenolol in Hypertension. A Report on 2,770 Patients in General Practice Originally Treated with Methyldopa
- 1 January 1976
- journal article
- research article
- Published by SAGE Publications in Scottish Medical Journal
- Vol. 21 (1) , 28-30
- https://doi.org/10.1177/003693307602100108
Abstract
Substitution, in part or totally, of the non-selective β-receptor antagonist oxprenolol for methyldopa in 2,770 treated hypertensive patients resulted in a significant reduction in blood pressure levels and a considerable improvement in the quality of the patient's life.This publication has 16 references indexed in Scilit:
- REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1974
- Letter: Hypertension and myocardial infarction.BMJ, 1974
- Side Effects of Hypotensive Agents Evaluated by a Self-administered QuestionnaireBMJ, 1973
- ANTIHYPERTENSIVE TREATMENT AND THE COURSE OF ESTABLISHED CEREBRAL VASCULAR DISEASEThe Lancet, 1973
- Role of Blood Pressure in the Development of Congestive Heart FailureNew England Journal of Medicine, 1972
- Systolic versus diastolic blood pressure and risk of coronary heart diseaseThe American Journal of Cardiology, 1971
- Epidemiologic Assessment of the Role of Blood Pressure in StrokeJAMA, 1970
- VISCERAL CHANGES IN SEVERE HYPERTENSION AND THEIR RESPONSE TO DRUG TREATMENTActa Medica Scandinavica, 1970
- METHYLDOPA IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1962
- ALPHA METHYL DOPA IN TREATMENT OF HYPERTENSIONThe Lancet, 1962